Gene Query: SH3BP5

Dataset Description Geneva Score
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 114.27
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 114.27
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 78.4
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 57.9
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 57.9
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 56.14
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 55.72
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 54.44
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 54.38
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 51.99
BCL11B 45.82
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 44.89
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 43.39
Genome wide expression change in LCC2 and MCF-7 cells 40.42
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 39.57
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 39.55
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 39.55
ZIKV infection of monocytes activates inflammasome pathways 39.38
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 38.98
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 36.8
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 36.41
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 36.22
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 35.78
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 35.78
CD86 regulates a pro-survival signal in myeloma cells 34.97
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 34.83
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 34.64
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 34.13
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 33.69
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 32.81
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 32.25
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 32.13
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 30.98
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 30.87
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 30.83
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 30.83
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 30.09
Gene expression profile of multiple myeloma cell lines treated with CB-5083 29.28
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 29.04
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 28.98
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 28.06
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 27.6
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 27.55
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 27.33
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 26.43
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 25.98
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 25.79
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 25.79
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 25.75
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 25.71
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 25.69
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 25.58
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 24.76
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 24.74
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 24.74
Real-time observation of light-controlled transcription in living cells 23.66
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 23.43
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 21.87
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 21.73
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 21.61
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 21.26
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 21.26
Clinker: visualizing fusion genes detected in RNA-seq data 21.16
Ro60-knockout cells 20.95
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 20.74
The transcriptome effect of overexpressing EZH2 in MCF7 20.38
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 20.36
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 20.31
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 20.26
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 20.05
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 20.02
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 19.71
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 19.57
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 19.42
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 19.01
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 19.01
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 18.85
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 18.78
A map of gene expression in neutrophil-like cell lines 18.78
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 18.64
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 18.58
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 18.58
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 18.51
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 18.5
RNAseq Analysis in glioblastoma cells treated with Mepazine 18.48
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 18.17
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 18.17
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 18.15
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 18.13
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 18.12
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 17.75
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 17.66
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 17.22
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 16.9
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 16.83
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 16.79
Tumor exosome integrins determine organotropic metastasis 16.63
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 16.34
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 16.34
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 16.23
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 16.23
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 16.22
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 16.22
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 16.19
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 16.18
Selective suppression of endothelial cytokine production by progesterone receptor 16.18
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 16.01
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 15.94
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 15.9
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 15.9
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 15.82
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 15.66
A549 cells and MSR-A549 cells 15.66
Gene expression analysis of the impact of TDP-43 knockout in human cells. 15.46
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 15.44
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 15.37
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 15.37
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 15.33
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 15.33
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 15.27
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 15.26
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 15.18
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 15.09
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 15.09
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 14.98
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 14.96
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 14.87
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 14.78
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 14.73
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 14.71
Be1 and Be2 B cells are transcriptionally distinct 14.7
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 14.54
Regionally specified human pluripotent stem cell-derived astrocytes 14.37
Transcriptome wide analysis of classically and alternatively activated macrophages 14.24
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 14.17
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 14.17
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 14.12
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 14.12
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 14.05
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 13.97
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 13.97
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 13.86
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 13.86
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 13.78
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 13.78
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 13.66
Transcriptome analysis of CNS leukemia 13.66
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 13.65
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 13.54
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 13.53
MARCKS and lnc-MARCKS act as inflammation regulators 13.51
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 13.49
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 13.35
Examining serotonergic neuron differentiation from human iPSCs 13.35
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 13.34
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 13.32
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 13.14
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 13.13
RNA-seq analysis to identify the genes regulated by p53-SET interplay 13.13
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 13.08
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 12.96
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 12.96
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 12.94
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 12.94
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 12.94
Landscape of H3K4me3 in human CD19 cells 12.92
Bone marrow derived human B cells [normal proB] 12.92
Differentially expressed vascular development genes for iPSC-ECs from CDI 12.89
Statins modulate endothelial transcriptional profile by inhibiting EZH2 12.87
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 12.7
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 12.7
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 12.65
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 12.58
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 12.58
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 12.55
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 12.5
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 12.45
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 12.31
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 12.27
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 12.17
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 12.14
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 12.14
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 11.89
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 11.89
circRNA profile in hypopharyngeal cancer 11.87
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 11.86
PNET animal model: new insights (II) 11.82
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 11.8
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 11.73
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 11.73
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 11.73
circRNA-sequencing 11.68
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 11.67
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 11.67
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 11.66
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 11.55
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 11.55
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 11.54
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 11.5
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 11.44
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 11.39
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 11.36
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 11.36
Epigenomic landscape during organ formation in human early embryos 11.29
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 11.26
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 11.21
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 11.16
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 11.11
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 11.06
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 11.03
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 11.02
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 10.93
Transcriptome of Stabilin-1 siRNA transfected human monocytes 10.9
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 10.83
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 10.83
EWSR1 influences alternative splicing through direct and indirect mechanisms 10.82
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 10.8
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 10.77
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 10.77
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 10.69
ARS2 is a general suppressor of pervasive transcription [RNAseq] 10.68
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 10.66
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 10.66
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 10.6
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 10.56
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 10.54
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 10.52
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 10.5
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 10.5
Characterization of human ILC2 subsets 10.46
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 10.46
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 10.46
Transcriptomic and gene ontology profiling of the human corneal cell types 10.39
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 10.39
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 10.31
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 10.3
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 10.25
Targeting MTHFD2 in Acute Myeloid Leukemia 10.22
Oncogenic roles of ARID5B in T-ALL 10.2
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 10.2
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 10.14
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 10.14
Transcriptome-wide response to synthetic chromatin protein PcTF 10.13
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 10.11
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 10.03
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 9.98
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 9.98
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 9.97
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 9.91
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 9.87
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 9.87
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 9.83
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 9.78
Interphase condensins regulate ligand-depedent enhancer activation 9.78
circNFIB suppresses lymphatic metastasis of pancreatic cancer 9.75
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 9.69
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 9.68
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 9.68
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 9.67
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 9.66
Genome-wide chromatin analysis of Ewing sarcoma 9.65
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 9.65
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 9.64
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 9.64
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 9.6
FOXP1 orchestration of ASD-relevant signaling pathways. 9.56
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 9.55
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 9.41
Global expression profiles in cardiac progenitor cells generated by ISX-9 9.41
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 9.38
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 9.35
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 9.35
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 9.27
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 9.26
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 9.25
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 9.13
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 9.11
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 9.07
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 9.07
Total RNA-seq in ALL-SIL upon TLX1 knockdown 9.06
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 9.03
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 9.03
NAPRT activation of macrophages 9.02
MeRIP-seq for heat shock in B-cell lymphoma cells 9.01
Redifferentiation of expanded human islet β cells by inhibition of ARX 9.0
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 8.96
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 8.94
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 8.89
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 8.86
Transcriptional effect of ETV1 knockdown in melanoma cells 8.61
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 8.58
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 8.57
Nucleoporin-mediated regulation of cell identity genes 8.56
Effects of rFVIIIFc on human macrophages 8.55
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 8.45
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 8.43
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 8.43
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 8.42
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 8.32
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 8.28
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 8.25
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 8.13
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 8.08
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 8.07
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 8.07
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 8.07
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 8.02
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 7.86
Anti-inflammatory effect of indoleacrylic acid (IA) 7.84
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 7.71
The cytokine environment influence on human skin-derived T cells 7.68
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 7.61
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 7.61
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 7.61
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 7.53
naive T cell heterogeneity after neonatal thymectomy 7.49
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 7.42
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 7.39
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 7.37
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 7.37
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 7.36
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 7.36
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 7.33
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 7.28
7.28
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 7.25
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 7.22
Transcriptomic analysis of the HOTAIR-regulated genes 7.2
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 6.96
Epigenome regulation during epidermal lineage commitment [RNA-seq] 6.91
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 6.91
mRNA expression profile of Lymphocytes by high-throuput sequencing 6.71
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 6.69
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 6.68
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 6.67
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 6.64
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 6.57
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 6.52
Hijacking of stress response machinery by oncogenes in acute leukaemia 6.47
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 6.47
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 6.44
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 6.44
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 6.29
Generation and persistence of human tissue-resident memory T cells in lung transplantation 6.28
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 6.25
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 6.25
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 6.13
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 6.05
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 5.97
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 5.94
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.93
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 5.93
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 5.87
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 5.86
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 5.76
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 5.69
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 5.66
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 5.66
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 5.48
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 5.48
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 5.48
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 5.43
Functional astrocytes differentiated from hiPSCs 5.41
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 5.38
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 5.31
Defective structural RNA processing in relapsing-remitting multiple sclerosis 5.29
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 5.28
Proteomics identifies a marker signature of MAPKi resistance in melanoma 5.27
Impact on erythroid progenitor type on erythroid differntiation 4.98
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 4.84
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 4.84
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 4.74
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 4.74
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 4.74
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 4.68
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.63
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 4.45
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 4.42
Disruption of GRIN2B impairs differentiation in human neurons 4.38
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 4.22
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 4.22
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 4.16
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 4.15
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 4.15
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 4.14
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 4.08
Trascriptome of thyroid cancer-induced macrophages 4.08
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 4.02
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 4.02
RNA-seq analysis and shRNA screen of breast cancer 3.99
RNA-seq analysis of breast cancer 3.99
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 3.99
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 3.98
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.94
Genome-wide Analysis of Chromatin Interactions in Human Cells 3.83
MAIT cell RNA sequencing 3.74
Gene expression profile of human placenta from T. Cruzi infected mothers 3.74
Transcriptome of activated human and mouse MAIT cells 3.72
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 3.59
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 3.56
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 3.42
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 3.39
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.33
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.33
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 3.18
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 3.17
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 3.17
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 3.17
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 3.13
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 3.09
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 3.09
Deep RNA sequencing of the human placental transcriptome 3.05
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.93
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 2.9
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.83
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 2.77
A novel target of EZH1/2 for treatment of mantle cell lymphoma 2.73
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.72
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 2.66
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 2.64
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 2.61
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.57
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 2.56
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.55
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 2.47
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 2.45
Human ovarian granulosa cell transcriptome 2.43
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 2.43
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 2.37
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 2.33
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 2.32
Leucegene: AML sequencing (part 6) 2.3
MHC Transcriptomic landscape at haplotype-specific resolution 2.19
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 2.18
Gene expression changes due to PARP knockdown in human cells 2.13
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.06
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.06
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.04
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.96
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.96
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.96
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 1.93
Dynamic 3D chromosomal landscapes in acute leukemia 1.93
RNA-Seq in PWS iPSC-derived neurons 1.88
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 1.87
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.87
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.8
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.8
RNA-seq of CD33 KO and control HSPCs 1.78
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.73
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.71
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.71
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.69
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.65
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.65
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 1.63
CUREfast: Accelerating research with families 1.57
Genome-wide identification of cancer-specific alternative splicing in circRNA 1.57
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.55
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 1.51
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 1.48
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.48
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.45
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.34
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 1.29
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 1.26
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 1.26
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.26
Gene expression of thyroid cancer cell lines 1.22
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.22
Gene expression analysis in response to hypoxic pathway inhibition 1.15
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 1.06
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 1.06
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.0
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.78
Gene expression analysis of breast cancer cell-lines 0.78
The role of m6A/m-RNA methylation in stress response regulation 0.75
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.75
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.74
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.74
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.71
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.65
Expression analysis of the TAF1 syndrome 0.65
Leucegene: ALL sequencing 0.49
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.37
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 0.36
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.35
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 0.27
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.26
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.25
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.25
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.23
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.21
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.2
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.17
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 0.17
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.13
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.11
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.04
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation